To accelerate patient access to innovative medicines and clinical trials for life-threatening diseases by establishing a reciprocal approval mechanism with trusted international regulatory authorities.
21 U.S.C. 351, 360bbb-8b
and
360n-2 42 U.S.C. 262(i)
Document Citations
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Fast-tracking Approval for Innovative Rare disease therapies Act. H.R. 7953. 119th
Cong., 2nd
sess., Introduced in House March 17, 2026. https://www.govinfo.gov/app/details/BILLS-119hr7953ih.
APA
Congress, House of Representatives (2026, March 17). Fast-tracking Approval for Innovative Rare disease therapies Act (H.R. 7953 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119hr7953ih.
MLA
United States, Congress, House of Representatives. Fast-tracking Approval for Innovative Rare disease therapies Act. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119hr7953ih. 119th Congress, H.R. 7953, Introduced in House 17 Mar. 2026.
Bluebook
H.R.7953 - 119th Congress (2025-2026): Fast-tracking Approval for Innovative Rare disease therapies Act, H.R.7953, 119th Cong. (2026), https://www.govinfo.gov/app/details/BILLS-119hr7953ih.
